BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28878029)

  • 1. IL4 Receptor-Targeted Proapoptotic Peptide Blocks Tumor Growth and Metastasis by Enhancing Antitumor Immunity.
    Vadevoo SMP; Kim JE; Gunassekaran GR; Jung HK; Chi L; Kim DE; Lee SH; Im SH; Lee B
    Mol Cancer Ther; 2017 Dec; 16(12):2803-2816. PubMed ID: 28878029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis.
    Vadevoo SMP; Kang Y; Gunassekaran GR; Lee SM; Park MS; Jo DG; Kim SK; Lee H; Kim WJ; Lee B
    Theranostics; 2024; 14(6):2605-2621. PubMed ID: 38646639
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of Tumor Growth against Chemoresistant Cholangiocarcinoma by a Proapoptotic Peptide Targeting Interleukin-4 Receptor.
    Permpoon U; Khan F; Vadevoo SMP; Gurung S; Gunassekaran GR; Kim MJ; Kim SH; Thuwajit P; Lee B
    Mol Pharm; 2020 Nov; 17(11):4077-4088. PubMed ID: 32881535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages.
    Gunassekaran GR; Poongkavithai Vadevoo SM; Baek MC; Lee B
    Biomaterials; 2021 Nov; 278():121137. PubMed ID: 34560422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth.
    Venmar KT; Kimmel DW; Cliffel DE; Fingleton B
    Biochim Biophys Acta; 2015 May; 1853(5):1219-28. PubMed ID: 25746764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting IL4/IL4R for the treatment of epithelial cancer metastasis.
    Bankaitis KV; Fingleton B
    Clin Exp Metastasis; 2015 Dec; 32(8):847-56. PubMed ID: 26385103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide.
    Lee C; Jeong H; Bae Y; Shin K; Kang S; Kim H; Oh J; Bae H
    J Immunother Cancer; 2019 Jun; 7(1):147. PubMed ID: 31174610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival.
    Cieslewicz M; Tang J; Yu JL; Cao H; Zavaljevski M; Motoyama K; Lieber A; Raines EW; Pun SH
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):15919-24. PubMed ID: 24046373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-genetic engineering of cytotoxic T cells to target IL-4 receptor enhances tumor homing and therapeutic efficacy against melanoma.
    Gunassekaran GR; Hong CM; Vadevoo SMP; Chi L; Guruprasath P; Ahn BC; Kim HJ; Kang TH; Lee B
    Biomaterials; 2018 Mar; 159():161-173. PubMed ID: 29329051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced delivery of liposomes to lung tumor through targeting interleukin-4 receptor on both tumor cells and tumor endothelial cells.
    Chi L; Na MH; Jung HK; Vadevoo SM; Kim CW; Padmanaban G; Park TI; Park JY; Hwang I; Park KU; Liang F; Lu M; Park J; Kim IS; Lee BH
    J Control Release; 2015 Jul; 209():327-36. PubMed ID: 25979323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.
    Malabarba MG; Rui H; Deutsch HH; Chung J; Kalthoff FS; Farrar WL; Kirken RA
    Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):865-72. PubMed ID: 8920992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective targeting of tumor associated macrophages in different tumor models.
    Kakoschky B; Pleli T; Schmithals C; Zeuzem S; Brüne B; Vogl TJ; Korf HW; Weigert A; Piiper A
    PLoS One; 2018; 13(2):e0193015. PubMed ID: 29447241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iRGD-targeted delivery of a pro-apoptotic peptide activated by cathepsin B inhibits tumor growth and metastasis in mice.
    Qifan W; Fen N; Ying X; Xinwei F; Jun D; Ge Z
    Tumour Biol; 2016 Aug; 37(8):10643-52. PubMed ID: 26867766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles for the interleukin-4 receptor and associated JAK/STAT proteins in human articular chondrocyte mechanotransduction.
    Millward-Sadler SJ; Khan NS; Bracher MG; Wright MO; Salter DM
    Osteoarthritis Cartilage; 2006 Oct; 14(10):991-1001. PubMed ID: 16682236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer.
    Singhal S; Stadanlick J; Annunziata MJ; Rao AS; Bhojnagarwala PS; O'Brien S; Moon EK; Cantu E; Danet-Desnoyers G; Ra HJ; Litzky L; Akimova T; Beier UH; Hancock WW; Albelda SM; Eruslanov EB
    Sci Transl Med; 2019 Feb; 11(479):. PubMed ID: 30760579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages.
    Zhou Q; Xian M; Xiang S; Xiang D; Shao X; Wang J; Cao J; Yang X; Yang B; Ying M; He Q
    Cancer Immunol Res; 2017 Jul; 5(7):547-559. PubMed ID: 28515123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages.
    Ngambenjawong C; Cieslewicz M; Schellinger JG; Pun SH
    J Control Release; 2016 Feb; 224():103-111. PubMed ID: 26772876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
    Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
    ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos.
    Bugawan TL; Mirel DB; Valdes AM; Panelo A; Pozzilli P; Erlich HA
    Am J Hum Genet; 2003 Jun; 72(6):1505-14. PubMed ID: 12748907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
    Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
    Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.